Skip to main content
. 2023 Nov 10;14(3):341–353. doi: 10.4103/njms.njms_174_22

Table 3.

Characteristics of the included studies

Author (Year) Origin country Study type Total patients#
Age (in years) Mean±SD (range) Modalities used Research object Tumor staging MRI machine MRI sequence Time between MRI recording and tumor resection
M F
Alsaffar et al. (2016)[99] Canada Prospective 53 64 Clinical, MRI, histopathological DOI T1–T4 NP NP NP
34 19
Jayasankaran et al. (2017)[96] India Prospective 59 51.81 (18–74) Clinical, MRI, histopathological DOI Infiltration of sublingual space Infiltration of extrinsic muscles Involvement of mylohyoid muscle T1–T4 3.0 Tesla T1WI spin echo T2WI T2WI with FS T1WI with FS Less than 1 week
42 17
Moreno et al.* (2017)[98] USA Prospective 20 58 (29–80) Clinical, MRI, histopathology DOI Cervical LN metastasis T1–T4 3.0 Tesla T1WI T2WI 1–40 days
14 6
Baba et al. (2019)[91] Japan Retrospective 28 66.2±15.2 (31–86) Clinical, MRI, histopathological DOI Locoregional control rate Disease-free SR Overall SR T1–T2 1.5 Tesla T1WI T2WI T1WI with FS NP
18 10
Mao et al. (2019)[93] China Prospective 150 58.01±12.10 Clinical, MRI, histopathological DOI Disease-specific SR Overall SR T1–T3 1.5 Tesla T1WI T2WI T2WI with FS 1 week
80 70
Murakami et al. (2019)[90] Japan Retrospective 29 (46–87) Clinical, MRI, histopathological DOI Recurrence pattern T2 3.0 Tesla T1WI T2WI CE T1WI STIR 1 month
15 14
Baba et al. (2019)[92] Japan Retrospective 45 63.4±16.1 (31–86) Clinical, MRI, histopathological DOI Cervical LN metastasis Locoregional control rate Disease-free SR Overall SR T1–T2 1.5 Tesla T1WI T2WI T1WI with FS NP
31 14
Vidiri et al.≤ (2020)[6] Italy Retrospective 43 (31–82) Clinical, MRI, histopathological DOI T1–T3 1.5 Tesla T1WI T2WI 3–4 weeks
18 25
Ravikanth (2020)[97] India Prospective 30 (41–70) Clinical, MRI, Histopathological DOI Cervical LN metastasis T1–T4 1.5 Tesla T1WI T2WI NP
27 3
Xu et al. (2020)[87] China Retrospective 151 57.1 (30–78) Clinical, MRI, histopathological DOI Cervical LN metastasis Disease-specific SR T1 3.0 Tesla T1WI T2WI T2WI with FS 1 week
111 40
Fu et al. (2020)[95] China Retrospective 156 58.7±9.2 (27–92) Clinical, MRI, histopathological DOI T1–T3 3.0 Tesla T1WI spin echo T2WI turbo spin echo T1WI with FS NP
95 61
Haraguchi et al. (2021)[88] Japan Retrospective 101 63.9 (22–88) Clinical, MRI, histopathological DOI Cervical LN metastasis T1–T4 NP T1WI T2WI NP
57 44
Baba et al. (2021)[1] Japan Retrospective 21 NP Clinical, MRI, CT, histopathological DOI T1–T3 1.5 Tesla T2WI T1WI with FS NP
16 5
Huopainen et al. (2021)[89] Finland Retrospective 45 NP Clinical, MRI, histopathological DOI T1–T3 1.5 Tesla or 3.0 Tesla T1WI with FS NP
NP
Mair et al. (2021)[100] UK Retrospective 60 56.7 Clinical, MRI, histopathological DOI T1–T4 1.5 Tesla Post-contrast, FS T1WI 2 weeks
40 20
Takamura et al. (2022)[8] Japan Retrospective 48 65.7 (23–90) Clinical, MRI, US, histopathological DOI T1–T2 1.5 Tesla T1WI with FS T2WI with FS 8–34 days
28 20
Tang et al. (2022)[94] China Retrospective 122 (28–76) Clinical, MRI, histopathological DOI T1–T3 3.0 Tesla T1WI T2WI with FS DWI e-THRIVE 2 weeks
78 44

#Patients with tongue carcinoma included in the analysis; *: the author used the term tumor thickness, which was confirmed to be DOI measurement after reading the full text

M: male; F: female; SD: standard deviation; MRI: magnetic resonance imaging; DOI: depth of invasion; NP: not provided; T1WI: T1-weighted image; T2WI: T2-weighted image; T: tumor; FS: fat suppression; CE: contrast-enhanced; STIR: short tau inversion recovery; SR: survival rate; CT: computed tomography; ≤: only mean difference was provided; LN: lymph node; US: ultrasound; DWI: diffusion-weighted image; e-THRIVE: dynamic enhanced T1 high-resolution isotropic volume examination